Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism.

about

Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism.

Item

http://www.wikidata.org/entity/Q40065692

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Real world experience with peg ...... favourable IL28B polymorphism.

@en

type

Item

label

Real world experience with peg ...... favourable IL28B polymorphism.

@en

prefLabel

Real world experience with peg ...... favourable IL28B polymorphism.

@en

P1476

Real world experience with peg ...... favourable IL28B polymorphism.

@en

P2093

Cynthia Sung

http://www.w3.org/2001/XMLSchema#string

Dorothy Toh

http://www.w3.org/2001/XMLSchema#string

Eng Kiong Teo

http://www.w3.org/2001/XMLSchema#string

Jessica Tan

http://www.w3.org/2001/XMLSchema#string

Mei Ling Yee

http://www.w3.org/2001/XMLSchema#string

Poh Yen Loh

http://www.w3.org/2001/XMLSchema#string

Rajneesh Kumar

http://www.w3.org/2001/XMLSchema#string

Victoria Ekstrom

http://www.w3.org/2001/XMLSchema#string

Wan Cheng Chow

http://www.w3.org/2001/XMLSchema#string

Yi Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Price and affordability of direct-acting antiviral regimens for hepatitis C virus in the United States

Direct anti-HCV agents

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

The role of interleukin-28b gene polymorphisms in chinese patients with chronic hepatitis C treated with pegylated interferon and ribavirin.

Global distribution and prevalence of hepatitis C virus genotypes.

IL28B genetic variations are associated with high sustained virological response (SVR) of interferon-α plus ribavirin therapy in Taiwanese chronic HCV infection.

P304

208-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GASTRO/GOW033

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28852525

http://www.w3.org/2001/XMLSchema#string

P932

5554392

http://www.w3.org/2001/XMLSchema#string